Heinrich R. Schelbert

Heinrich R. Schelbert's AcademicInfluence.com Rankings

Philosophy

#4805

World Rank

#7455

Historical Rank

Logic

#2188

World Rank

#3123

Historical Rank

philosophy Degrees

Heinrich R. Schelbert

Biology

#6370

World Rank

#9067

Historical Rank

Physiology

#154

World Rank

#327

Historical Rank

biology Degrees

Download Badge

Philosophy
Biology

Heinrich R. Schelbert's Degrees

Masters Medicine University of Zurich
PhD Physiology University of Zurich

Why Is Heinrich R. Schelbert Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Heinrich R. Schelbert's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Reversibility of cardiac wall-motion abnormalities predicted by positron tomography. (1986) (1343)
Noninvasive quantification of regional blood flow in the human heart using N-13 ammonia and dynamic positron emission tomographic imaging. (1990) (568)
Anatomic versus physiologic assessment of coronary artery disease. Role of coronary flow reserve, fractional flow reserve, and positron emission tomography imaging in revascularization decision-making. (2013) (490)
Influence of Age and Hemodynamics on Myocardial Blood Flow and Flow Reserve (1993) (486)
Quantitative relation between myocardial viability and improvement in heart failure symptoms after revascularization in patients with ischemic cardiomyopathy. (1995) (478)
Identification and Differentiation of Resting Myocardial Ischemia and Infarction in Man with Positron Computed Tomography, 18F‐labeled Fluorodeoxyglucose and N‐13 Ammonia (1983) (447)
N‐13 Ammonia as an Indicator of Myocardial Blood Flow (1981) (434)
ASNC imaging guidelines/SNMMI procedure standard for positron emission tomography (PET) nuclear cardiology procedures (2016) (389)
Positron emission tomography and autoradiography: Principles and applications for the brain and heart (1985) (387)
Improvements in cancer staging with PET/CT: literature-based evidence as of September 2006. (2007) (365)
Relation among stenosis severity, myocardial blood flow, and flow reserve in patients with coronary artery disease. (1995) (359)
Cardiac PET imaging for the detection and monitoring of coronary artery disease and microvascular health. (2010) (353)
Regional perfusion, glucose metabolism, and wall motion in patients with chronic electrocardiographic Q wave infarctions: evidence for persistence of viable tissue in some infarct regions by positron emission tomography. (1986) (325)
Simple noninvasive quantification method for measuring myocardial glucose utilization in humans employing positron emission tomography and fluorine-18 deoxyglucose. (1989) (296)
Positron emission tomography detects tissue metabolic activity in myocardial segments with persistent thallium perfusion defects. (1987) (294)
Sustained regional abnormalities in cardiac metabolism after transient ischemia in the chronic dog model. (1985) (294)
Long-term survival of patients with coronary artery disease and left ventricular dysfunction: implications for the role of myocardial viability assessment in management decisions. (1998) (276)
13N ammonia myocardial imaging at rest and with exercise in normal volunteers. Quantification of absolute myocardial perfusion with dynamic positron emission tomography. (1989) (275)
Positron tomography with deoxyglucose for estimating local myocardial glucose metabolism. (1982) (274)
Quantification of Regional Myocardial Blood Flow Using 13N‐Ammonia and Reoriented Dynamic Positron Emission Tomographic Imaging (1992) (261)
Noninvasive assessment of coronary stenoses by myocardial imaging during pharmacologic coronary vasodilation. VI. Detection of coronary artery disease in human beings with intravenous N-13 ammonia and positron computed tomography. (1982) (258)
Coronary Circulatory Dysfunction in Insulin Resistance, Impaired Glucose Tolerance, and Type 2 Diabetes Mellitus (2005) (254)
Investigation of [18F]2-fluoro-2-deoxyglucose for the measure of myocardial glucose metabolism. (1978) (246)
Regional myocardial perfusion assessed with N-13 labeled ammonia and positron emission computerized axial tomography. (1979) (239)
Myocardial imaging with thallium-201: a multicenter study in patients with angina pectoris or acute myocardial infarction. (1978) (228)
Relationship between increasing body weight, insulin resistance, inflammation, adipocytokine leptin, and coronary circulatory function. (2006) (223)
Nontraumatic determination of left ventricular ejection fraction by radionuclide angiocardiography. (1975) (212)
Regional myocardial metabolism in patients with acute myocardial infarction assessed by positron emission tomography. (1986) (205)
C- 11 labeled palmitic acid for the noninvasive evaluation of regional myocardial fatty acid metabolism with positron-computed tomography. I. Kinetics of C- 11 palmitic acid in normal myocardium. (1982) (198)
Validation of [1-11C]acetate as a tracer for noninvasive assessment of oxidative metabolism with positron emission tomography in normal, ischemic, postischemic, and hyperemic canine myocardium. (1990) (195)
Serial measurements of left ventricular ejection fraction by radionuclide angiography early and late after myocardial infarction. (1976) (189)
Right Ventricular Ejection Fraction in Patients with Acute Anterior and Inferior Myocardial Infarction Assessed by Radionuclide Angiography (1978) (181)
C- 11 labeled palmitic acid for the noninvasive evaluation of regional myocardial fatty acid metabolism with positron-computed tomography. II. Kinetics of C- 11 palmitic acid in acutely ischemic myocardium. (1982) (180)
Regional myocardial oxygen consumption determined noninvasively in humans with [1-11C]acetate and dynamic positron tomography. (1989) (176)
Effects of long-term smoking on myocardial blood flow, coronary vasomotion, and vasodilator capacity. (1998) (175)
Positron emission tomography and autoradiography (1985) (173)
Coronary Vasomotor Abnormalities in Insulin-Resistant Individuals (2004) (172)
Comparison of maximal myocardial blood flow during adenosine infusion with that of intravenous dipyridamole in normal men. (1992) (166)
Effect of short-term cardiovascular conditioning and low-fat diet on myocardial blood flow and flow reserve. (1995) (165)
Alterations in regional myocardial metabolism, perfusion, and wall motion in Duchenne muscular dystrophy studied by radionuclide imaging. (1984) (160)
Noninvasive quantification of myocardial blood flow in humans. A direct comparison of the [13N]ammonia and the [15O]water techniques. (1996) (160)
Effects of afterload reduction (diuretics and vasodilators) on left ventricular volume and mitral regurgitation in severe congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. (1987) (159)
Left ventricular ejection fraction--a review of several radionuclide angiographic approaches using the scintillation camera. (1978) (155)
Positron Emission Tomography Imaging of Cardiac Reporter Gene Expression in Living Rats (2002) (151)
Reproducibility of measurements of regional resting and hyperemic myocardial blood flow assessed with PET. (1996) (149)
Radiolabeled Acetate as a Tracer of Myocardial Tricarboxylic Acid Cycle Flux (1988) (149)
Noninvasive quantitation of regional myocardial oxygen consumption in vivo with [1-11C]acetate and dynamic positron emission tomography. (1989) (149)
Positron emission tomography-measured abnormal responses of myocardial blood flow to sympathetic stimulation are associated with the risk of developing cardiovascular events. (2005) (145)
Measurements of regional tissue and blood-pool radiotracer concentrations from serial tomographic images of the heart. (1983) (145)
Optical Imaging of Cardiac Reporter Gene Expression in Living Rats (2002) (141)
PET myocardial perfusion and metabolism clinical imaging (2009) (138)
PET detection of viable tissue in myocardial segments with persistent defects at T1-201 SPECT. (1989) (137)
Effect of acute and long-term smoking on myocardial blood flow and flow reserve. (1995) (136)
Procedure guideline for tumor imaging using fluorine-18-FDG. Society of Nuclear Medicine. (1998) (136)
Insights Into Coronary Artery Disease Gained From Metabolic Imaging (1988) (136)
Factor analysis for extraction of blood time-activity curves in dynamic FDG-PET studies. (1995) (134)
Parametric images of myocardial metabolic rate of glucose generated from dynamic cardiac PET and 2-[18F]fluoro-2-deoxy-d-glucose studies. (1991) (131)
C-11 palmitate for the noninvasive evaluation of regional myocardial fatty acid metabolism with positron computed tomography. III. In vivo demonstration of the effects of substrate availability on myocardial metabolism. (1983) (130)
Assessment of myocardial viability by dobutamine echocardiography, positron emission tomography and thallium-201 SPECT: correlation with histopathology in explanted hearts. (1998) (129)
Incidence of abnormal positron emission tomography in patients with unexplained cardiomyopathy and ventricular arrhythmias: The potential role of occult inflammation in arrhythmogenesis. (2015) (129)
Effects of dobutamine stimulation on myocardial blood flow, glucose metabolism, and wall motion in normal and dysfunctional myocardium. (1996) (129)
Interventricular septal motion and left ventricular function after coronary bypass surgery: evaluation with echocardiography and radionuclide angiography. (1977) (126)
L-Arginine normalizes coronary vasomotion in long-term smokers. (1999) (125)
Simultaneous measurement of myocardial oxygen consumption and blood flow using [1-carbon-11]acetate. (1998) (124)
Positron emission tomography myocardial perfusion and glucose metabolism imaging (2006) (123)
Measurement of regional myocardial blood flow with N-13 ammonia and positron-emission tomography in intact dogs. (1985) (122)
A BOUNDARY METHOD FOR ATTENUATION CORRECTION IN POSITRON COMPUTED TOMOGRAPHY (1981) (121)
Role of thallium-201 and PET imaging in evaluation of myocardial viability and management of patients with coronary artery disease and left ventricular dysfunction. (1994) (121)
Afterload reduction with vasodilators and diuretics decreases mitral regurgitation during upright exercise in advanced heart failure. (1990) (116)
A simplified method for quantification of myocardial blood flow using nitrogen-13-ammonia and dynamic PET. (1993) (113)
Retention and clearance of C-11 palmitic acid in ischemic and reperfused canine myocardium. (1985) (111)
Effect of Oral Propranolol on Rest, Exercise and Postexercise Left Ventricular Performance in Normal Subjects and Patients with Coronary Artery Disease (1981) (109)
Cardiac Emission Computed Tomography: Underestimation of Regional Tracer Concentrations Due to Wall Motion Abnormalities (1984) (108)
Lymphoscintigraphy with Tc-99m-labeled dextran. (1982) (108)
Positron-Emission Tomography Reporter Gene Expression Imaging in Rat Myocardium (2003) (107)
Phase I, First-in-Human Study of BMS747158, a Novel 18F-Labeled Tracer for Myocardial Perfusion PET: Dosimetry, Biodistribution, Safety, and Imaging Characteristics After a Single Injection at Rest (2011) (104)
Coronary microvascular resistance: methods for its quantification in humans (2009) (104)
Regional myocardial blood flow and metabolism at rest in mildly symptomatic patients with hypertrophic cardiomyopathy. (1989) (104)
In vivo quantitation of regional myocardial blood flow by positron-emission computed tomography. (1981) (103)
Comparison of Clinical Tools for Measurements of Regional Stress and Rest Myocardial Blood Flow Assessed with 13N-Ammonia PET/CT (2012) (101)
Effect of caffeine on myocardial blood flow at rest and during pharmacological vasodilation. (1995) (98)
Regional Myocardial Blood Flow and Glucose Utilization in Symptomatic Patients With Hypertrophic Cardiomyopathy (1993) (97)
Anatomy and physiology of coronary blood flow (2010) (95)
Left ventricular geometry and function in adults with Ebstein's anomaly of the tricuspid valve. (1987) (92)
C-11 palmitate for the noninvasive evaluation of regional myocardial fatty acid metabolism with positron-computed tomography. IV. In vivo evaluation of acute demand-induced ischemia in dogs. (1983) (92)
Noninvasive Assessment of Coronary Microcirculatory Function in Postmenopausal Women and Effects of Short-Term and Long-Term Estrogen Administration (2002) (92)
Positron emission tomography for the assessment of myocardial viability. (1991) (92)
Differentiating cardiomyopathy of coronary artery disease from nonischemic dilated cardiomyopathy utilizing positron emission tomography. (1991) (91)
Quantification of myocardial blood flow using 13N-ammonia and PET: comparison of tracer models. (1999) (90)
Pet myocardial perfusion and glucose metabolism imaging: Part 2-guidelines for interpretation and reporting (2003) (90)
Procedure Guideline for Myocardial Perfusion Imaging 3.3* (2008) (89)
Detection of Perioperative Myocardial Damage after Coronary Artery Bypass Graft Surgery (1977) (89)
Effects of substrate availability on myocardial C-11 palmitate kinetics by positron emission tomography in normal subjects and patients with ventricular dysfunction. (1986) (85)
Factors affecting myocardial 2-[F-18]fluoro-2-deoxy-d-glucose uptake in positron emission tomography studies of normal humans (1993) (84)
Prevalence of myocardial viability as detected by positron emission tomography in patients with ischemic cardiomyopathy. (1999) (84)
Dual myocardial imaging with technetium-99m pyrophosphate and thallium-201 for detecting, localizing and sizing acute myocardial infarction. (1977) (83)
PET-measured responses of MBF to cold pressor testing correlate with indices of coronary vasomotion on quantitative coronary angiography. (2004) (83)
Chronic Inflammation and Impaired Coronary Vasoreactivity in Patients With Coronary Risk Factors (2004) (80)
Noninvasive Measurement of Myocardial Activity Concentrations and Perfusion Defect Sizes in Rats With a New Small-Animal Positron Emission Tomograph (2002) (80)
Assessment of regional myocardial ischemia by positron-emission computed tomography. (1982) (79)
The need for standardisation of cardiac FDG PET imaging in the evaluation of myocardial viability in patients with chronic ischaemic left ventricular dysfunction (2002) (78)
Positron computed tomography for studies of myocardial and cerebral function. (1983) (78)
Electrocardiographic gating in positron emission computed tomography. (1979) (77)
Effects of cardiac allograft vasculopathy on myocardial blood flow, vasodilatory capacity, and coronary vasomotion. (1997) (77)
Abnormal Longitudinal, Base-to-Apex Myocardial Perfusion Gradient by Quantitative Blood Flow Measurements in Patients With Coronary Risk Factors (2001) (75)
Primary hemochromatosis: anatomic and physiologic characteristics of the cardiac ventricles and their response to phlebotomy. (1984) (75)
Myocardial viability in asynergic regions subtended by occluded coronary arteries: relation to the status of collateral flow in patients with chronic coronary artery disease. (1994) (74)
Evaluation of the effect of glucose ingestion and kinetic model configurations of FDG in the normal liver. (1994) (73)
Quantitative measurement of myocardial blood flow with oxygen-15 water and positron computed tomography: an assessment of potential and problems. (1985) (73)
Positron emission tomography detects metabolic viability in myocardium with persistent 24-hour single-photon emission computed tomography 201Tl defects. (1992) (73)
Standardization of cardiac tomographic imaging (1992) (72)
Assessment of the effects of dobutamine on myocardial blood flow and oxidative metabolism in normal human subjects using nitrogen-13 ammonia and carbon-11 acetate. (1993) (72)
Determinants of myocardial blood flow response to cold pressor testing and pharmacologic vasodilation in healthy humans (2006) (72)
Coronary Circulatory Function in Patients with the Metabolic Syndrome (2011) (71)
Metabolic imaging to assess myocardial viability. (1994) (70)
Dobutamine positron emission tomography: absolute quantitation of rest and dobutamine myocardial blood flow and correlation with cardiac work and percent diameter stenosis in patients with and without coronary artery disease. (1996) (69)
PET/CT Imaging: Facts, Opinions, Hopes, and Questions (2004) (68)
Regional myocardial blood flow, metabolism and function assessed noninvasively with positron emission tomography. (1980) (68)
Effect of beta 1 adrenergic receptor blockade on myocardial blood flow and vasodilatory capacity. (1997) (67)
Noninvasive determination of myocardial blood flow, oxygen consumption and efficiency in normal humans by carbon-11 acetate positron emission tomography imaging (1999) (66)
Identification of impaired metabolic reserve by atrial pacing in patients with significant coronary artery stenosis. (1986) (66)
Semiquantitative assessment of myocardial blood flow and viability using polar map displays of cardiac PET images. (1992) (65)
Role of PET in the evaluation and understanding of coronary physiology (2007) (64)
Use of the metabolic tracer carbon-11-acetate for evaluation of regional myocardial perfusion. (1991) (64)
Radionuclide angiographic evaluation of ventricular function in isolated congenitally corrected transposition of the great arteries. (1986) (63)
Rabbit myocardial 82Rb kinetics and a compartmental model for blood flow estimation. (1989) (61)
Quantification of myocardial blood flow using dynamic nitrogen-13-ammonia PET studies and factor analysis of dynamic structures. (1995) (60)
Emission tomography of the heart. (1980) (60)
Effect of mental stress on myocardial blood flow and vasomotion in patients with coronary artery disease. (2000) (59)
Quantification of absolute myocardial perfusion at rest and during exercise with positron emission tomography after human cardiac transplantation. (1991) (58)
Assessment of intra- and interobserver reproducibility of rest and cold pressor test-stimulated myocardial blood flow with 13N-ammonia and PET (2007) (57)
Quantitative Assessment of Prolonged Metabolic Abnormalities in Reperfused Canine Myocardium (1992) (57)
Derivation of input function from FDG-PET studies in small hearts. (1996) (57)
Noninvasive measurement of cardiovascular function in mice with high-temporal-resolution small-animal PET. (2006) (57)
Noninvasive assessment of left ventricular performance in patients with chronic obstructive pulmonary disease. (1977) (57)
Blood flow-metabolism imaging with positron emission tomography in patients with diabetes mellitus for the assessment of reversible left ventricular contractile dysfunction. (1999) (56)
Improvement in coronary endothelial function is independently associated with a slowed progression of coronary artery calcification in type 2 diabetes mellitus. (2009) (56)
Left Ventricular Performance Assessed by Radionuclide Angiocardiography and Echocardiography in Patients with Previous Myocardial Infarction (1975) (56)
Quantification and parametric imaging of renal cortical blood flow in vivo based on Patlak graphical analysis. (1993) (55)
Improvement in coronary vascular dysfunction produced with euglycaemic control in patients with type 2 diabetes (2006) (55)
Evaluation of myocardial metabolism, with N-13- and C-11-labeled amino acids and positron computed tomography. (1982) (55)
Usefulness of preoperative and postoperative Tc-99m (Sn)-pyrophosphate scans in patients with ischemic and valvular heart disease. (1977) (54)
Inhibition of glyceraldehyde-3-phosphate dehydrogenase in post-ischaemic myocardium. (1996) (53)
Issues in the quantitation of reoriented cardiac PET images. (1992) (53)
Use of nonionic or low osmolar contrast agents in cardiovascular procedures. American College of Cardiology Cardiovascular Imaging Committee. (1993) (52)
Noninvasive assessment of myocardial perfusion and metabolism: feasibility of registering gated MR and PET images. (1995) (50)
Procedure guideline for myocardial perfusion imaging. Society of Nuclear Medicine. (1998) (50)
Validation of a model for [1-11C]acetate as a tracer of cardiac oxidative metabolism. (1994) (49)
Myocardial Blood Flow at Rest and During Pharmacological Vasodilation in Cardiac Transplants During and After Successful Treatment of Rejection (1994) (48)
18F-deoxyglucose and the assessment of myocardial viability. (2002) (47)
Quantitative relation between hemodynamic changes during intravenous adenosine infusion and the magnitude of coronary hyperemia: implications for myocardial perfusion imaging. (2005) (46)
A quantitative index of regional blood flow in canine myocardium derived noninvasively with N-13 ammonia and dynamic positron emission tomography. (1991) (46)
L-[4-11C]aspartic acid: enzymic synthesis, myocardial uptake, and metabolism (1982) (45)
Procedure guideline for myocardial perfusion imaging (1998) (45)
Catheter ablation for cardiac arrhythmias: clinical applications, personnel and facilities. American College of Cardiology Cardiovascular Technology Assessment Committee. (1994) (45)
Current status and prospects of new radionuclides and radiopharmaceuticals for cardiovascular nuclear medicine. (1987) (44)
Structural alterations of the coronary arterial wall are associated with myocardial flow heterogeneity in type 2 diabetes mellitus (2009) (44)
Regulation of pyruvate dehydrogenase activity and glucose metabolism in post-ischaemic myocardium. (1998) (43)
Influence of dietary state and insulin on myocardial, skeletal muscle and brain [18F]-fluorodeoxyglucose kinetics in mice (2011) (42)
Relationship between Tl-201, Tc-99m (Sn) pyrophosphate and F-18 2-deoxyglucose uptake in ischemically injured dog myocardium. (1987) (41)
The Future of Nuclear Medicine, Molecular Imaging, and Theranostics. (2020) (41)
PET Contributions to Understanding Normal and Abnormal Cardiac Perfusion and Metabolism (2000) (41)
Correction of spillover radioactivities for estimation of the blood time-activity curve from the imaged LV chamber in cardiac dynamic FDG PET studies. (1995) (41)
Coronary circulatory function abnormalities in insulin resistance: insights from positron emission tomography. (2009) (41)
Diagnostic and clinical perspectives of fusion imaging in cardiology: is the total greater than the sum of its parts? (2005) (40)
Parameter estimation of cardiac geometry by ECG-gated PET imaging: validation using magnetic resonance imaging and echocardiography. (1995) (40)
Trimetazidine-induced enhancement of myocardial glucose utilization in normal and ischemic myocardial tissue: an evaluation by positron emission tomography. (1998) (40)
Effect of hormone replacement therapy on vasomotor function of the coronary microcirculation in post-menopausal women with medically treated cardiovascular risk factors. (2008) (39)
Assessment of mitral valve E point-septal separation as an index of left ventricular performance in patients with acute and previous myocardial infarction. (1978) (39)
A new noninvasive quantification of renal blood flow with N-13 ammonia, dynamic positron emission tomography, and a two-compartment model. (1992) (38)
Compartment model for measuring myocardial oxygen consumption using [1-11C]acetate. (1997) (37)
Myocardial viability: methods of assessment and clinical relevance. (1996) (37)
Coronary vasodilator reserve and Framingham risk scores in subjects at risk for coronary artery disease (2006) (36)
Observations on Factors Affecting Local Forces in the Left Ventricular Wall during Acute Myocardial Ischemia (1971) (35)
Evidence for preserved cardiopulmonary baroreflex control of renal cortical blood flow in humans with advanced heart failure. A positron emission tomography study. (1995) (35)
Coronary vascular dysfunction in premenopausal women with diabetes mellitus. (2002) (35)
Positron Emission Tomography in Oncology (1988) (35)
Investigation of a new input function validation approach for dynamic mouse microPET studies. (2004) (35)
Measurement of regional glucose metabolic rates in reperfused myocardium. (1991) (34)
Synthesis and myocardial kinetics of N-13 and C-11 labeled branched-chain L-amino acids. (1983) (34)
Detection of Fungal Vegetations Involving a Starr-Edwards Mitral Prosthesis by Means of Ultrasound (1972) (34)
Effects of modified pharmacologic stress approaches on hyperemic myocardial blood flow. (1995) (33)
PET-measured heterogeneity in longitudinal myocardial blood flow in response to sympathetic and pharmacologic stress as a non-invasive probe of epicardial vasomotor dysfunction (2006) (33)
Performance of the rotating slant-hole collimator for the detection of myocardial perfusion abnormalities. (1982) (32)
Assessment of regurgitant fraction and right and left ventricular function at rest and during exercise: a new technique for determination of right ventricular stroke counts from gated equilibrium blood pool studies. (1982) (31)
Quantification of myocardial blood flow: what is the clinical role? (2009) (31)
Beneficial effect of residual anterograde flow on tissue viability as assessed by positron emission tomography in patients with myocardial infarction. (1987) (31)
The usefulness of positron emission tomography. (1998) (30)
Effects of Inhibition of Fatty Acid Oxidation on Myocardial Kinetics of 11C-Labeled Palmitate (1989) (30)
Delayed recovery of revascularized myocardium after referral for cardiac transplantation. (1990) (30)
Myocardial perfusion and viability by positron emission tomography in infants and children with coronary abnormalities: correlation with echocardiography, coronary angiography, and histopathology. (2003) (30)
Cardiac Abnormalities in Primary Hemochromatosis (1988) (29)
Task force 5: Training in nuclear cardiology (1995) (29)
Effect of exercise supplementation during adenosine infusion on hyperemic blood flow and flow reserve. (1994) (28)
Regulation of myocardial blood flow response to mental stress in healthy individuals. (2000) (28)
Blood flow and metabolism by PET. (1994) (27)
Nitrogen-13 ammonia cardiac positron emission tomography in mice: effects of clonidine-induced changes in cardiac work on myocardial perfusion (2003) (27)
Positron emission tomography: a new method for determination of renal function. (1993) (26)
Euglycemic hyperinsulinemic clamp and oral glucose load in stimulating myocardial glucose utilization during positron emission tomography. (1992) (26)
The Influence of Insulin Resistance, Obesity, and Diabetes Mellitus on Vascular Tone and Myocardial Blood Flow (2012) (26)
Semiautomatic Software For Quantitative Analysis Of Cardiac Positron Tomography Studies (1988) (25)
FFR and coronary flow reserve: friends or foes? (2012) (25)
Responses of blood flow, oxygen consumption, and contractile function to inotropic stimulation in stunned canine myocardium. (1994) (25)
Positron Emission Tomography of the Heart: Methodology, Findings in the Normal and the Diseased Heart, and Clinical Applications (2004) (25)
Uhl's anomaly (parchment right ventricle): clinical, echocardiographic, radionuclear, hemodynamic and angiocardiographic features in 2 patients. (1984) (25)
Positron emission tomography measurements of myocardial blood flow: assessing coronary circulatory function and clinical implications (2012) (25)
Coronary vasodilatory capacity is impaired in patients with dilated cardiomyopathy. (1996) (24)
Myocardial perfusion imaging: Lessons learned and work to be done—update (2018) (24)
Studies of fatty acid metabolism with positron emission tomography in patients with cardiomyopathy (2004) (24)
Diagnostic value of PET-measured heterogeneity in myocardial blood flows during cold pressor testing for the identification of coronary vasomotor dysfunction (2007) (23)
Imaging metabolism and biochemistry--a new look at the heart. (1983) (23)
Long-Term Survival of Patients with Viable and Nonviable Aneurysms Assessed by 99mTc-MIBI SPECT and 18F-FDG PET: A Comparative Study of Medical and Surgical Treatment (2008) (23)
Positron emission tomography demonstrates that coronary sinus retroperfusion can restore regional myocardial perfusion and preserve metabolism. (1991) (22)
Coronary vasodilatory capacity and flow reserve in normal myocardium supplied by bypass grafts late after surgery. (1997) (22)
Relation of myocardial perfusion at rest and during pharmacologic stress to the PET patterns of tissue viability in patients with severe left ventricular dysfunction (1998) (22)
Metabolic and ultrastructural abnormalities during ischemia in canine myocardium: noninvasive assessment by positron emission tomography. (1987) (22)
Positron emission tomography - A new approach to brain chemistry (1988) (21)
Noninvasive quantification of hepatic arterial blood flow with nitrogen-13-ammonia and dynamic positron emission tomography. (1991) (21)
Pet imaging in small animals (2003) (21)
INDs for PET Molecular Imaging Probes—Approach by an Academic Institution (2014) (21)
Measurements of myocardial metabolism in patients with ischemic heart disease. (1998) (20)
Dosimetry, biodistribution, and safety of flurpiridaz F 18 in healthy subjects undergoing rest and exercise or pharmacological stress PET myocardial perfusion imaging (2018) (20)
13N-labeled L-amino acids for in vivo assessment of local myocardial metabolism. (1981) (20)
In Vivo Quantitation of Regional Myocardial Blood Flow by Positron‐emission Computed Tomography (1981) (19)
Myocardial ischemia and clinical applications of positron emission tomography. (1989) (19)
Merits and limitations of radionuclide approaches to viability and future developments (1994) (19)
Noninvasive Assessment of Myocardial Function (1980) (19)
A refined method for quantification of myocardial oxygen consumption rate using mean transit time with carbon-11-acetate and dynamic PET. (1993) (18)
Myocardial perfusion reserve in adults with cyanotic congenital heart disease. (2005) (17)
Blood flow, flow reserve, and glucose utilization in viable and nonviable myocardium in patients with ischemic cardiomyopathy (2013) (17)
A Public Domain Dynamic Mouse FDG MicroPET Image Data Set for Evaluation and Validation of Input Function Derivation Methods (2006) (17)
Ammonia Myocardial Imaging at Rest and With Exercise in Normal Volunteers Quantification of Absolute Myocardial Perfusion With Dynamic Positron Emission Tomography (2005) (16)
Factor Analysis for Extraction of Blood (1995) (16)
Society of Nuclear Medicine Procedure Guideline for Myocardial Perfusion Imaging version 3 . 0 , approved June 15 , 2002 (2002) (16)
Guidelines for training in adult cardiovascular medicine. Core Cardiology Training symposium (COCATS) Task Force 5: Training in Nuclear Cardiology (1995) (15)
Utilization of the radionuclide cardiac angiogram for determination of cardiac output and ejection fraction. (1975) (15)
Nuclear Medicine at a Crossroads (2011) (15)
IMAGING GUIDELINES FOR NUCLEAR CARDIOLOGY PROCEDURES A Report of The American Society of Nuclear Cardiology Quality Assurance Committee (2006) (15)
Cyclotrons and Radiopharmaceuticals in Positron Emission Tomography (1988) (14)
A New Technique For Elastic Registration Of Tomographic Images (1988) (14)
Application of positron emission tomography in the heart. Council on Scientific Affairs. Report of the Positron Emission Tomography Panel. (1988) (14)
PET/CT in cancer patient management. Introduction. (2007) (14)
Position statement: clinical use of cardiac positron emission tomography. Position paper of the Cardiovascular Council of the Society of Nuclear Medicine. (1993) (13)
N-13 Labeled Ammonia and Positron Emission Computerized Axial Tomography (1979) (13)
Regional myocardial dysfunction in patients with angina at rest and response to isosorbide dinitrate assessed by phase analysis of radionuclide ventriculograms. (1984) (13)
Usefulness of pre- and postoperative Tc-99m-pyrophosphate scans in cardiac surgical patients☆ (1976) (12)
National Cancer Institute workshop statement: Advances in clinical imaging using positron emission tomography, September 14-16, 1988 (1990) (12)
Phase 1 rest-stress study of F-18 labeled BMS747158 myocardial perfusion PET tracer: Human safety, dosimetry, biodistribution, and myocardial imaging characteristics (2009) (12)
Measurement of C-11 palmitate kinetics after metabolic interventions in normals and patients with cardiomyopathy using positron emission computed tomography (1982) (12)
First human study of BMS747158, a novel F-18 labeled tracer for myocardial perfusion imaging (2008) (12)
Quantification of the extent and severity of perfusion defects in canine myocardium by PET polar mapping. (1994) (11)
Regional abnormality of oxygen consumption in reperfused myocardium assessed with [1-11C] acetate and positron emission tomography (1989) (11)
Positron emission tomography in human myocardial ischemia. (1987) (10)
Positron tomography of the heart. (1980) (10)
Dynamic positron tomographic imaging with nitrogen-13 glutamate in patients with coronary artery disease: comparison with nitrogen-13 ammonia and fluorine-18 fluorodeoxyglucose imaging. (1990) (10)
Positron computed tomography for the in vivo assessment of regional myocardial function. (1984) (10)
Relative sensitivity of Tc-99m-pyrophosphate and thallium 201 for diagnosing acute myocardial infarction☆ (1976) (10)
American Society of Nuclear Cardiology Practice Guidelines PET Myocardial Glucose Metabolism and Perfusion Imaging Part 1 — Guidelines for Patient Preparation and Data Acquisition (2003) (9)
Noninvasive quantification of regional myocardial blood flow: assessment of myocardial perfusion reserve and collateral circulation. (1990) (9)
Incidental Detection of Elastofibroma Dorsi With 68Ga-FAPI-46 and 18F-FDG PET/CT in a Patient With Esophageal Cancer. (2020) (9)
Cardiac PET: Microcirculation and substrate transport in normal and diseased human myocardium (1994) (9)
Non-traumatic determination of cardiac output and left ventricular ejection fraction by radionuclide angiography (1974) (8)
Positron emission tomography and the changing paradigm in coronary artery disease (2000) (8)
Assessment of cerebral glucose metabolism in patients with heart failure by 18F-FDG PET/CT imaging (2020) (8)
Clinical application of radionuclide angiography (1995) (8)
Cardiac motion and fiber shortening: the whole and its parts. (2006) (8)
Doxorubicin cardiotoxicity: Response of left ventricular ejection fraction to exercise and incidence of regional wall motion abnormalities (1988) (8)
Different roads to the assessment of myocardial viability. Lessons from PET for SPECT. (1995) (7)
Task Force 5: training in nuclear cardiology: endorsed by the American Society of Nuclear Cardiology. (2006) (7)
Noninvasive detection of functionally significant coronary artery stenoses with exercise and positron emission tomography. (1991) (7)
Time-course of ”redistribution” of thallium-201 administered during transient ischemia (1979) (7)
Metabolism in non-ischemic myocardium during coronary artery occlusion and reperfusion. (1993) (7)
L-[4-11C]aspartic acid: enzymatic synthesis, myocardial uptake, and metabolism. (1982) (7)
Task force 5: training in nuclear cardiology endorsed by the American Society of Nuclear Cardiology. (2008) (6)
Glucose metabolism of regional myocardial ischemia evaluated by 18fluoro-2-deoxyglucose and positron emission computed tomography (1980) (6)
Are the irreversible perfusion defects on myocardial thallium scans really irreversible? (1988) (6)
Attenuated response of glucose metabolism in reperfused canine myocardium to changes in substrate levels (1990) (6)
Measurement of MBF by PET is ready for prime time as an integral part of clinical reports in diagnosis and risk assessment of patients with known or suspected CAD (2018) (6)
Assessment of myocardial viability with positron emission tomography (2000) (6)
PET Quantitation of Myocardial Blood Flow (2003) (6)
Myocardial viability in patients with ischemic cardiomyopathy-evaluation by 3-D integration of myocardial scintigraphic data--and coronary angiographic data. (2004) (6)
Deoxyglucose method for the estimation of local myocardial glucose metabolism with positron computed tomography (1981) (6)
Cost effectiveness of Positron Emission Tomography (PET) in the management of ischemic cardiomyopathy patients who are referred for cardiac transplantation (1996) (6)
Features of positron emission tomography as a probe for myocardial chemistry (2004) (5)
Recovery of glucose metabolism in reperfused canine myocardium demonstrated by positron-CT (PCT) (1984) (5)
Left ventricular blood TAC quantitation with microPET imaging in mice using MAP, FBP and blood sampling (2005) (5)
Positron computed tomography and its applications in the young. (1985) (5)
Mechanism of action of a novel metabolically active antianginal agent (trimethazidine) delineated by PET (1996) (5)
Cardiac norepinephrine stores and chronotropic reflex response after thoracotomy. (1975) (5)
Quantitation of Myocardial Perfusion: Absolute Blood Flow Versus Relative Uptake (2013) (5)
Positron emission tomography. The technique and its applications to the study of the cardiovascular system. (1983) (5)
Toward an improved understanding and management of human heart transplant recipients. (1992) (5)
Quantitation of regional myocardial blood flow by positron emission tomography (1980) (5)
Cardiovascular metabolic imaging: physiologic and biochemical dynamics in vivo. (1985) (5)
Assessment of myocardial metabolism by PET —a sophisticated dream or clinical reality? (2004) (5)
Physiologic tomography: A new means for the non-invasive measurement of myocardial metabolism, blood flow and function (1980) (5)
Instrumentation in Positron Emission Tomography (1988) (5)
Clinical cardiac PET: Quo vadis? (1994) (4)
Nuclear medicine: a new tool in the diagnosis of cardiac disease. (1981) (4)
Positron emission computed tomography (1985) (4)
Assessment of mitral valve e point-septal separation as an index of left ventricular function in acute and chronic ischemic heart disease (1978) (4)
Same day rest-stress protocols for PET imaging with the new F-18 labeled BMS747158 myocardial perfusion tracer (2009) (4)
Head and Neck Region (2008) (4)
Non-invasive quantification of myocardial blood flow and flow reserve using dynamic positron emission tomography. (1994) (4)
Correlation of myocardial necrosis with kinetics of 111In-labeled myosin-specific antibody in isolated rabbit septum. (1991) (4)
Blood flow-dependent uptake of indium-111 monoclonal antimyosin antibody in canine acute myocardial infarction. (1993) (4)
Positron-Emission Tomography Quantitative Measurements of Myocardial Blood Flow: Just the Facts…. (2019) (4)
First-pass angiography in mice using FDG-PET: a simple method of deriving the cardiovascular transit time without the need of region-of-interest drawing (2005) (4)
Society of Nuclear Medicine Procedure Guideline for Tumor Imaging Using F-18 FDG version 2 . 0 , approved February 7 , 1999 (1999) (4)
Evaluation of "metabolic fingerprints" of myocardial ischemia. (1986) (4)
Assessment of Blood Flow and Substrate Metabolism in the Myocardium of the Normal Human Heart (1996) (3)
New concepts in cardiac imaging 1985 (1985) (3)
Metabolic and functional fate of viable myocardium by pet early after acute infarction (1991) (3)
Positron emission tomography (1988) (3)
Basal myocardial blood flow is increased but maximal flow is decreased during acute cardiac transplant rejection: A non-invasive quantitative study (1991) (3)
Chapter 11 – State-of-the-Art Instrumentation for PET and SPECT Imaging in Small Animals (2010) (3)
METABOLIC ABNORMALITIES ADJACENT TO ISCHEMIC MYOCARDIUM IN DOGS DEMONSTRATED BY POSITRON TOMOGRAPHY (PET) (1984) (3)
Myocardial Blood Flow and Flow Reserve (2005) (3)
Identification of residual viable tissue in chronic ECG Q wave infarcts with positron emission tomography (1985) (3)
Positron emission tomography of the heart (1979) (3)
Metabolic tissue characterization in patients with acute myocardial infarction with positron tomography (1985) (3)
Consideration of Measurements of Myocardial Blood Flow with Positron‐Emission Tomography (1993) (3)
Artifactual reductions of segmental indicator tissue concentrations on tomographic images of the heart caused by regional wall motion abnormalities (1984) (3)
Heart and respiratory gating of cardiac microPET/sup /spl reg///CT studies in mice (2004) (3)
Intravenous myocardial imaging performed serially early and late after acute myocardial infarction (1977) (3)
Effects of ACAT inhibition by positron emission tomography measured myocardial blood flow: A double-blind, randomized, multicenter trial (2003) (3)
Doxorubicin Cardiotoxicity : Response of Left Ventricular Ejection Fraction to Exercise and Incidence of Regional Wall Motion Abnormalities (1985) (3)
Positron emission tomography. Diagnostic and therapeutic implications in human myocardial ischemia. (1987) (2)
Persistent twenty-four hour SPECT thallium-201 defects, plasma thallium-201 concentrations and PET metabolic viability. (1994) (2)
Preoperative determination of reversibility of wall motion abnormalities using F-18 fluorodeoxyglucose and N-13 ammonia positron tomography (1984) (2)
Clinical significance of reduced glucose uptake in myocardial regions with preserved blood flow in patients with coronary artery disease (1996) (2)
Noninvasive Detection of 47% Diameter Coronary Stenosis by Myocardial Emission Computed Tomography of Nitrogen-13 Ammonia During Pharmacologic Coronary Vasodilation in Intact Dogs (1980) (2)
816-4 Effect of glucose lowering on coronary circulatory dysfunction in type 2 diabetes mellitus (2004) (2)
Chapter 33 – Myocardial Blood Flow Measurement: Evaluating Coronary Pathophysiology and Monitoring Therapy (2010) (2)
Linking myocardial metabolism and viability using radionuclide techniques (1999) (2)
Noninvasive Measurement of Left- Ventricular Performance Utilizing an Anger Camera—Left- Ventricular Ejection Fraction (1977) (2)
Quantifying Myocardial Perfusion for the Assessment of Preclinical CAD (2007) (2)
Components of professional competence for nuclear medicine physicians. (2003) (2)
[Effect of pentazocine (Fortral) on pulmonary circulation]. (1973) (2)
PET for Detection and Reporting Coronary Microvascular Dysfunction: A JACC: Cardiovascular Imaging Expert Panel Statement. (2023) (2)
[Positron emission tomography: principles and uses in cardiology]. (1992) (1)
Prognostic value of a normal rest-stress myocardial perfusion positron emission tomography (PET): a long term follow up study (1998) (1)
[The effect of N-(n-propyl)-ajmalinium-hydrogentartrate on canine hemodynamics]. (1973) (1)
Response of absolute myocardial blood flow to dobutamine assessed with nitrogen-13 ammonia and dynamic positron emission tomography (1991) (1)
Quantification of Absolute Myocardial Perfusion With Dynamic Positron Emission Tomography (2005) (1)
Accuracy of early pet blood flow and metabolic measurements for predicting late improvement in the clinical infarct zone (1991) (1)
Cardiovascular transit times in mice by high temporal resolution microPET (2004) (1)
Do We Need PET? (2014) (1)
Combined dynamic and gated C-11 acetate pet imaging provides estimates of myocardial oxygen extraction and wall tension (1991) (1)
Tc-99m DEXTRAN: A NEW AGENT FOR LYMPHOSCINTIGRAPHY (1981) (1)
Influence of insulin and fasting on myocardial, muscle and brain [18F]-FDG uptake and kinetics in mice (2006) (1)
Recombinant Tissue Inhibitor Subdues Matrix Metalloproteinases and Produces Novel Images With New Possibilities. (2019) (1)
SPECT and 18 F-FDG PET: A Comparative Study of Medical and Surgical Treatment (2008) (1)
Insulin-sensitizing thiazolidinedione improves coronary endothelial dysfunction in insulin resistance by PET measurements of myocardial blood flow (2002) (1)
[Impact of viable myocardium assessed by 99Tcm-MIBI SPECT and 18F-FDG PET imaging on clinical outcome of patients with left ventricular aneurysm underwent revascularization]. (2008) (1)
Effect of cold pressor testing and Iv L-arginine on coronary vasomotion in patients with Syndrome X (1996) (1)
Quantitation of Infarct Size in Rat Myocardium Using F-18 Deoxyglucose and a New High-Resolution microPET System (1998) (1)
Imaging with infarct-avid agents. (1981) (1)
Abnormal coronary vasomotor response to mental stress in patients with coronary artery disease (CAD) (1998) (1)
Effects of tissue uptake and kidney excretion of FDG on the blood FDG clearance in mice (2007) (1)
Cardiac PET and PET/CT (2008) (1)
[Positron-computer tomography: a new method for the quantitative determination of metabolism, blood supply and function of the heart]. (2008) (1)
Assessment of ventricular function by radionuclide techniques. (1980) (1)
Kinetics of C-ll labeled palmitate in ischemic myocardium (1981) (1)
Coronary vasodilatory capacity and flow reserve are attenuated in normal myocardium supplied by bypass grafts (1996) (1)
Preface: The new frontier in nuclear cardiology (1994) (1)
Positron Emission Tomography for the Noninvasive Study and Quantitation of Myocardial Blood Flow and Metabolism in Cardiovascular Disease. (2004) (1)
Metabolic borderzone in acutely ischemic canine myocardium demonstrated by positron-CT (PCT) (1984) (1)
Metabolic abnormalities adjacent to ischemic myocardium in dogs demonstrated by positron emission tomography (1984) (1)
Effects of inhibition of. beta. -oxidation on tissue kinetics of C-11 palmitate in normal myocardium (1985) (1)
The prevalence of viable myocardium in 288 patients with congestive heart failure (1998) (1)
RELATION BETWEEN SEVERITY OF RELATIVE MYOCARDIAL BLOOD FLOW REDUCTION AND GLUCOSE METABOLIC ACTIVITY IN PATIENTS WITH CHRONIC ISCHEMIC HEART DISEASE.: P2 (1986) (1)
DEVELOPMENT OF AN AUTOMATED REGISTRATION ALGORITHM FOR DETECTION AND CORRECTION OF PATIENT MOVEMENT IN CARDIAC PET IMAGING (1992) (1)
Comments and Perspectives (2004) (1)
A videotechnique for recording continuously left ventricular wall motion and changes in wall thickness. (1974) (1)
Effect of glucose lowering on coronary vascular function, carotid intima-media thickness and coronary artery calcification in type 2 diabetes mellitus (2009) (1)
Nuclear Imaging Techniques for the Evaluation of TMLR (1999) (1)
Positron Computed Tomography: A New Method for Quantitative Measurement of Cardiac Metabolism, Perfusion and Function of the Heart - I. Technical and Experimental Details (1983) (1)
Evaluation of Myocardiai Metaboiism, withN-13-andC-i 1-Labeled Amino AcidsandPositronComputedTomography (1982) (0)
Metabolic characteristics of the infarct zone: PET findings (1996) (0)
Nitrogen-13-labeled L-amino acids for in vivo assessment of local myocardial metabolism (1981) (0)
Myocardial perfusion imaging: Lessons learned and work to be done-Update By Editors of J Nuc Cardiol (2019) (0)
Left ventricular function assessed by radionuclide angiography and echocardiography in patients with previous myocardial infarction (1975) (0)
Abstract 3950: Deficiency of PPAR{gamma} in Cardiomyocytes Results in Myocardial Inflammation and Cardiac Insulin Resistance (2009) (0)
Comprar Oncologic and Cardiologic PET/CT-Diagnosis · An Interdisciplinary Atlas and Manual | Mohnike, Wolfgang | 9783540740902 | Springer (2008) (0)
948-46 Preserved Cardiac Baroreflex Control of Renal Cortical Blood Flow in Advanced Heart Failure Patients: A Positron Emission Tomography Study (1995) (0)
PET Imaging and Coronary Circulatory Function: Non-Invasive Mechanistic Insights and Cardiovascular Prognosis (2006) (0)
Assessment of myocardial injury after reperfusion with T1-201, Tc-99m pyrophosphate (PPi) and F-18 deoxyglucose (FDG) (1984) (0)
Myocardial viability (1995) (0)
EXPERIMENTAL STUDIES Retention and Clearance of C-ll Palmitic Acid in Ischemic and Reperfused Canine Myocardium (2010) (0)
Cost-effectiveness of cardiac positron emission tomography in the treatment of ischemic cardiomyopathy. (1996) (0)
Myocardial flow reserve in viable and nonviable myocardium in patients with ischemic cardiomyopathy and severe left ventricular dysfunction (2007) (0)
Book Review Clinical Nuclear Cardiology By George A. Beller. 387 pp., illustrated. Philadelphia, W.B. Saunders, 1995. $95. 0-7216-3332-3 (1996) (0)
Streamlined quantification of absolute MBF at rest and stress with flurpiridaz F-18 injection PET in normal subjects and patients with coronary artery disease (CAD) (2011) (0)
Is Positron Emission Tomography Derived Absolute Myocardial Blood Flow Reproducible (1992) (0)
[Relations between coronary vessel changes and disturbances of local myocardial function]. (1973) (0)
Travels with Henry (2006) (0)
Nuklearkardiologie: Situation in Europa (2011) (0)
Kardiovaskuläre PET/CT in den USA (2016) (0)
DIAGNOSTIC METHODS (1972) (0)
Cardiovascular Radiology (1984) (0)
Oncologic and Cardiologic PET/CT-Diagnosis (2008) (0)
A 3-Year-Old Girl With Recent Onset of Seizures and Asymmetric Hypermetabolic Activity on 18F-FDG PET/CT. (2021) (0)
MEASUREMENT OF REGIONAL PHYSIOLOGIC PROCESSES IN THE HUMAN HEART USING POSITRON EMISSION TOMOGRAPHY (1993) (0)
Dermatologie: Malignes Melanom (MM) (2011) (0)
[Cardiologic applications of positron emission tomography]. (1994) (0)
Noninvasive measurement of regional myocardial glucose metabolism by positron emission computed tomography. [Dogs] (1980) (0)
EVALUATION OF FLUORODEOXYGLUCOSE(FDG) AS A GLUCOSE ANALOG IN MYOCARDIUM WITH 2‐t‐GLUCOSE.: F5 (1983) (0)
Emission computed tomography: a new technique for the quantitative physiologic study of brain and heart in vivo (1978) (0)
HOW DOES THE NUMBER OF NORMALS AFFECT THE RELIABILITY OF A NORMAL REFERENCE DATABASE (1992) (0)
A good beginning with an uncertain future (2019) (0)
[The integration of positron emission tomography into noninvasive cardiovascular diagnosis]. (1992) (0)
Coronary artery calcification is associated with myocardial blood flow heterogeneity in subclinical type-2 diabetes mellitus (2007) (0)
Inter and intra observer variability of myocardial blood flow measurements using positron emission tomography (1995) (0)
Noninvasive Evaluation and Quantification of Regional Myocardial Blood Flow (1983) (0)
[Proceedings: Regional myocardial function in coronary heart disease measured by mean velocity of fiber shortening (author's transl)]. (1973) (0)
[Echocardiographic serial study on movements of the interventricular septum after aorto-coronary bypass]. (1978) (0)
Focus on Molecular Imaging (2007) (0)
PET impacts patient care of coronary artery disease. (1992) (0)
Left ventricular functional impairment in chronic heart failure patients is independent of extent of perfusion defects and viable myocardium (2002) (0)
Myocardial metabolism, perfusion, wall motion and electrical activity in Duchenne muscular dystrophy (1982) (0)
Poster display IV experimental and instrumentation (2005) (0)
Limitations of quantitative phase analysis for detection of coronary artery disease in patients with impaired LV-function (1983) (0)
JNM tops impact factor rankings for imaging journals. (2009) (0)
Beneficial effect of β-blockade on hyperemic myocardial blood flow and vasodilatory capacity in humans (1995) (0)
Image-Based Measurements of Myocardial Blood Flow (2015) (0)
INCREASED FDG UPTAKE IN REPERFUSED CANINE MYOCARDIUM REPRESENTS SUSTAINED ANAEROBIC METABOLISM: P22 (1986) (0)
Daniel S. Berman, MD, born on July 15, 1944 (2021) (0)
MicroPET imaging of myocardial insulin resistance in mice deficient of the cardiomyocyte PPAR{gamma} (2007) (0)
Left Ventricular Performance Assessed by Radionuclide Angiocardiography and Echocardiography (2005) (0)
METABOLIC TISSUE CHARACTERIZATION BY PET IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION (1984) (0)
Nuclear Cardiology — the Situation in Europe (2008) (0)
Myocardial Blood Flow and Oxidative Metabolism Findings in Normal and Diseased Myocardium (1991) (0)
MYOCARDIAL ISCHEMIA Identification of impaired metabolic reserve by atrial pacing in patients with significant coronary artery stenosis (2005) (0)
Cardiovascular nuclear medicine 1980 (1980) (0)
IS POSITRON EMISSION TOMOGRAPHY DERIVED ABSOLUTE MYOCARDIAL BLOOD FLOW, GLUCOSE UTILIZATION AND OXIDATIVE METABOLISM REPRODUCIBLE? (1993) (0)
Positron Emission Tomography Detects Metabolic Viabilit in Myocardium With Persistent 24-Hour Single-Photon Emission Computed Tomography 201 T 1 Defects (2005) (0)
Beneficial long-term effect of hormone replacement therapy on coronary vasomotion in postmenopausal women with treated coronary risk factors (2008) (0)
The Mikamo lecture. Probing the heart's biochemistry with positron emission tomography. (1986) (0)
One additional year of training in nuclear medicine: will it help or hurt? (2002) (0)
Current BER Scientists: Principal Investigators (2001) (0)
Myocardial Blood Flow and Perfusion: Radionuclide Techniques (2002) (0)
Effects of Modffied Pharmacologic Stress Approaches on Hyperemic Myocardial Blood Flow (2006) (0)
[Aneurysms and fistulas of the Valsalva sinus]. (1974) (0)
Findings in Myocardial Ischemia by Metabolic Imaging with Positron Emission Tomography (1990) (0)
Metabolic consequences of myocardial ischemia and assessment of coronary sinus interventions (1986) (0)
LABORATORY OF NUCLEAR MEDICINE AND RADIATION BIOLOGV 900 VETERAN AVENUE UNIVERSITY OF CALIFORNIA, LOS ANGELES, CALIFORNIA 90024 AND DEPARTMENT OF RADIOLOGICAL SCIENCES UCLA SCHOOL OF MEDICINE, LOS AMGELES, CALIFORNIA 90024 These studies were supported by Contract #DE-AM03-76-SF00012 between the U.S. (2009) (0)
Is there a relationship between inflammatory biomarkers and coronary vasomotor function (2007) (0)
Effect of age and menopausal status on indices of coronary vasomotion in women without coronary risk factor (2005) (0)
Regional myocardial perfusion evaluated in humans at rest using rubidium-82 with gamma-camera imaging (1987) (0)
Noninvasive measurement of local myocardial glucose uptake with F-18 deoxyglucose and positron tomography (1982) (0)
A Final Editor's Note (2011) (0)
Recipes for Human Albumin Macroaggregates. (2020) (0)
Guidelines for training in adult cardiovascular medicine. Core Cardiology Training Symposium (COCATS). Task Force 5: training in nuclear cardiology. American College of Cardiology and the American Society of Nuclear Cardiology. (1995) (0)
Let’s functionalize the myocardial flow reserve (2021) (0)
Myocardial blood flow and metabolism in humans. (1984) (0)
[Continuous determination of left ventricular wall thickness using an automatic procedure]. (1972) (0)
Capturing Photons More Efficiently. (2020) (0)
ASSESSMENT OF LEFT VENTRICULAR DYSFUNCTION DURING RESTING ANGINA AND RESPONSE TO NITRATES BY PHASE ANALYIS OF RADIONUCLIDE ANGIOGRAPHY: B7 (1983) (0)
8.2 Abnormal longitudinal base to apex myocardial perfusion gradient by quantitative blood flow measurements in patients with coronary risks (2001) (0)
Emission Tomography (2005) (0)
A NEW APPROACH FOR THE NON INVASIVE DETECTION OF RELATIVE CHANGES IN AORTIC REGURGITATION BETWEEN REST & EXERCISE (1982) (0)
METABOLIC IN VIVO TISSUE CHARACTERIZATION OF REPERFUSED MYOCARDIUM BY POSITRON‐CT (PCT) IN A CHRONIC DOG MODEL: A3 (1983) (0)
[The perioperative myocardial infarct after aortocoronary bypass]. (1977) (0)
Myocardial perfusion and coronary vasomotor function: Emerging role of PET imaging (2007) (0)
[Correlations between coronary-arterial lesions and myocardial function (author's transl)]. (1974) (0)
Abstract 2428: Reproducibility of PET-Measured Myocardial Blood Flow Responses to Cold-Pressor-Testing. (2006) (0)
ARE GENDER OR PHARMACOLOGIC STRESS-SPECIFIC REFERENCE NORMAL DATABASES NECESSARY FOR QUANTITATIVE ANALYSIS OF STRESS N-13 AMMONIA PET IMAGES? (1992) (0)
Improvement in heart failure symtoms after revascularization in patients with ischemic cardiomyopathy predicted by PET (1995) (0)
CALIPSO: A software for quantitative analysis of cardiac images on a macintosh computer (1990) (0)
Factors affecting recovery of left ventricular function after mitral valve surgery (1978) (0)
Assessment of Myocardial Viability by Radionuclide Techniques (2000) (0)
On the Relativity of Dipyridamole and Dobutamine Flows (2020) (0)
Atlas of Cardiac Positron Emission Tomography (1994) (0)
[Movement course and change of wall thickness in dyskinetic and akinetic myocardial regions]. (1972) (0)
JNM Editor, SNM Members Receive Imaging Awards (2006) (0)
Diagnosis — Methods for Evaluating Myocardial Microcirculation in Patients (1982) (0)
Cardiac nuclear medicine By Byron E. Gerson McGraw‐Hill Book Company, New York (1987) ISBN: 0‐07‐023184‐2 (1987) (0)
Future perspectives: diagnostic possibilities with positron emission tomography. (1990) (0)
Radiolabeled acetate kinetics and tricarboxylic acid cycle flux in the rat heart (1987) (0)
Diagnostic value of global and longitudinal myocardial flow responses to sympathetic stress for identification of abnormal coronary vasomotor function (2007) (0)
811-3 Beneficial Effect of β-Blockade on Myocardial Blood Flow and Vasodilator Capacity in Humans (1995) (0)
[Positron computed tomography: a new method for quantitative determination of cardiac metabolism, blood circulation and function. I. Technical and experimental bases]. (1983) (0)
Assessment Of Left Ventricular Ejection Fraction By Radionuclide Angiography Comparison to Echocardiography and Serial Measurements in Patients with Myocardial Infarction (1976) (0)
Positron Emission Tomography Detects Metabolic Viabilit in Myocardium With Persistent 24‐Hour Single‐Photon Emission Computed Tomography 201T1 Defects (1992) (0)
A NOVEL METABOLICALLY ACTIVE ANTIANGINAL AGENT (TRIMETHAZIDINE) ENHANCES PET MEASURED GLUCOSE UTILIZATION (1995) (0)
Recent progress in nuclear cardiology (2002) (0)
Nuclear Medicine Professionals Meet in Beijing (2011) (0)
N-13 ammonia for the noninvasive evaluation of myocardial blood flow by positron emission computed tomography (1979) (0)
Positron computed tomography: current state, clinical results and future trends (1980) (0)
[Videometric determination of the left ventricular area with semi-automated correction for background structures]. (1972) (0)
Regional Myocardial Metabolism by Positron Emission Tomography (1988) (0)
23-4 Gender differences in effect of mental stress on myocardial blood flow: A quantitative PET study (1997) (0)
Assessment of the metabolic heart-brain axis with cardiac and brain 18F-FDG PET/CT imaging in patients with heart failure (2020) (0)
A new method of deriving the mice cardiovascular transit time without the need of region-of-interest drawing (2004) (0)
Panel Discussion Marker of Ischemia, Marker of Reperfusion Injury (1986) (0)
Metabolic Imaging with PET in the Critically Ill Patient with Coronary Artery Disease (1988) (0)
Positron Emission Tomography for the Assessment of Myocardial Viability in Acute Myocardial Infarction (1988) (0)
Cardiovascular Nuclear Medicine (1975) (0)
C-11 acetate traces both oxidative metabolism and blood flow in human myocardium (1990) (0)
Kopf-Hals-Region (2011) (0)
Advances in Cardiac Applications for PET and PET/CT (2004) (0)
Metabolic tissue characterization of reperfused canine myocardium by C-11 palmitic acid (1983) (0)
[The perforation of a sinus valsalva aneurysma in the differential diagnosis of acute myocardial infarction (author's transl)]. (1974) (0)
[Cardiac positron emission tomography--current status and future perspectives]. (1990) (0)
[Cineventricular analysis of local myocardial function in healthy subjects and patients with coronary disease (author's transl)]. (1973) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Heinrich R. Schelbert?

Heinrich R. Schelbert is affiliated with the following schools:

University of California, Los Angeles

Heinrich R. Schelbert's Academic­Influence.com Rankings

Heinrich R. Schelbert's Degrees

Why Is Heinrich R. Schelbert Influential?

Heinrich R. Schelbert's Published Works

Published Works

What Schools Are Affiliated With Heinrich R. Schelbert?

Heinrich R. Schelbert's AcademicInfluence.com Rankings